GlassScriptPhysician profile
James K Matheson
NPI 1023095726
$2,158.71
in general payments reported to CMS, 2019-2025
29 companies · $107 in 2025
The $107 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $268 · 2020: $368 · 2021: $481 · 2022: $578 · 2023: $333 · 2024: $23.69 · 2025: $107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $464.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $463.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $540.55 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $156.18 | 2023 | Myfembree |
| Agile Therapeutics, INC. | $149.14 | 2021-2024 | Twirla |
| Myovant Sciences INC. | $137.18 | 2021-2022 | |
| Amgen INC. | $124.51 | 2020 | |
| Hologic Sales and Service, LLC | $118.99 | 2019-2022 | |
| Pfizer INC. | $111.25 | 2019-2023 | |
| Meditrina | $106.97 | 2025 | |
| Astellas Pharma US INC | $91.13 | 2020-2023 | Myrbetriq, Veozah |
| Organon LLC | $80.86 | 2022 | |
| Medtronic, INC. | $72.89 | 2022-2023 | Interstim |
| Axonics, INC. | $70.01 | 2021-2023 | Axonics |
| Therapeuticsmd, INC. | $68.14 | 2019-2022 | |
| Minerva Surgical, INC | $43.19 | 2020-2023 | |
| Lupin INC. | $34.52 | 2020-2021 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $33.17 | 2022-2023 | Saffron |
| Mylan Pharmaceuticals INC. | $32.43 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $20.19 | 2023 | Exparel |
| Sage Therapeutics, LLC | $18.03 | 2022 | |
| Boston Scientific Corporation | $17.48 | 2019 | |
| Roche Diagnostics Corporation | $17.11 | 2019 | |
| Scynexis, INC. | $16.80 | 2022 | |
| Amag Pharmaceuticals, INC. | $16.29 | 2019 | |
| Cook Medical LLC | $15.45 | 2019 | |
| Coopersurgical, INC. | $14.66 | 2022 | |
| Ethicon US, LLC | $14.07 | 2019 | |
| Currax Pharmaceuticals LLC | $12.95 | 2022 | |
| Duchesnay USA Incorporated | $12.70 | 2019 | |
| Mission Pharmacal Company | $11.87 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Matheson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.